The Zerigo Health Platform uses proprietary technology and human coaching to help patients with chronic skin disease manage their care, minimizing the need for biologic medications which cost ~$40-80k per year. These costs are expected to grow between 17-50% per year creating an unsustainable burden for payers and patients. To address this challenge, Zerigo Health leverages its patented NB-UVB device, an easy-to-use mobile app, and personal member support to treat mild to moderate psoriasis and eczema in an accessible, convenient, and personalized way.